U.S. HHS Reports Progress on Import Safety Action Plan, Rx Groups To Further Collaborate
This article was originally published in PharmAsia News
Executive Summary
An import "safety summit" being convened July 9 features a multi-stakeholder medical products panel moderated by U.S. FDA Commissioner Andrew von Eschenbach